There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the innovative drug candidate AC102 have been promising. AudioCure Pharma, a Berlin-based start-up…

Dr. Maik Pietzner receives a W2 professorship for life for “Health Data Modeling” at the Berlin Institute of Health at Charité (BIH). His aim is to find disease-specific small changes in genes and thus target structures for innovative drugs. Using…

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Science Immunology.” The detailed insights into…

- Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma

- Orphan Drug Designation follows outstanding preclinical data and FDA IND…

Labomatic Instruments AG and KNAUER Wissenschaftliche Geräte GmbH are pleased to announce a strategic cooperation aimed at combining their complementary strengths to offer a larger portfolio to their respective customer bases.

The DRFZ and the Faculty of Medicine at the University of Tottori in Japan have signed an agreement on an academic exchange program.

Building a community for bringing advanced and regenerative therapies to the patients

"Get Ready for Japan" training programme

Physical activity is not only important for fitness but also for overall health. This is confirmed by a new study conducted under the leadership of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE).…

Prospects for personalized medicine in Crohn’s disease